Ajanta Pharma Limited
AJANTPHARM
Rank in Stocks
#3710
Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited... Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited operates as a specialized pharmaceutical enterprise. This company, along with its subsidiaries, is dedicated to the development, manufacturing, and commercialization of finished dosage forms. Its extensive product range caters to numerous therapeutic categories, such as anti-infectives (antibiotic, anti-malarial), chronic disease management (anti-diabetic, cardiology), women's health (gynecology), pediatrics, respiratory ailments, general health, dermatology, ophthalmology, and pain management. Notable products include multivitamins, antibiotics, eye drops, and cough syrups. Ajanta Pharma boasts a substantial international footprint, operating across India, Africa, other parts of Asia, the United States, and additional global markets. Furthermore, it supplies its pharmaceutical offerings to various government entities, including armed forces, public hospitals, and governmental procurement departments.
Share Price
$36.41
Last synced: 2026-10-19
Market Cap
$4.55B
Change (1 day)
-0.54%
Change (1 year)
31.32%
Country
IN
Trade Ajanta Pharma Limited (AJANTPHARM)
Category
Healthcare
Earnings for Ajanta Pharma Limited (AJANTPHARM)
Earnings in Jun 2026 TTM: $164.80M
According to Ajanta Pharma Limited latest financial reports the company's current earnings are $164.80M. In 2024 the company made an earning of $133.59M, an increase over its 2023 earnings that were of $90.68M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Ajanta Pharma Limited from 2005 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $164.80M | 18.53% |
| 2025 | $139.04M | 4.08% |
| 2024 | $133.59M | 47.31% |
| 2023 | $90.68M | -24.31% |
| 2022 | $119.81M | -2.57% |
| 2021 | $122.97M | 39.52% |
| 2020 | $88.14M | 19.01% |
| 2019 | $74.06M | -22.54% |
| 2018 | $95.62M | -4.34% |
| 2017 | $99.95M | 20.97% |
| 2016 | $82.63M | 13.06% |
| 2015 | $73.08M | 32.80% |
| 2014 | $55.03M | 69.13% |
| 2013 | $32.54M | 81.39% |
| 2012 | $17.94M | 41.32% |
| 2011 | $12.69M | 47.07% |
| 2010 | $8.63M | 46.96% |
| 2009 | $5.87M | -18.63% |
| 2008 | $7.22M | 61.49% |
| 2007 | $4.47M | 39.66% |
| 2006 | $3.20M | 48.67% |
| 2005 | $2.15M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 970.72% |
IN
|
